Drug intelligence / Profile preview

Yi-Shen-Hua-Shi

Development stage
Preclinical
Lead developer
Guangdong Consun Pharmaceutical Group
Administration
Oral
01

Overview

Yi-Shen-Hua-Shi (YSHS) is a patented traditional Chinese medicine formulated as granules, consisting of a mixture of 16 herbs. [1, 2] It is developed and manufactured by Guangzhou Consun Pharmaceutical Co. Ltd. [1, 12, 13] YSHS is used clinically for the treatment of various kidney diseases, including chronic kidney disease (CKD), IgA nephropathy (IgAN), diabetic kidney disease (DKD), and chronic glomerulonephritis. [1, 4, 9, 16] Clinical and preclinical studies have shown that it can improve renal function, reduce proteinuria, and alleviate edema. [1, 4] The mechanism of action is complex and multifactorial, involving the modulation of the gut microbiota (the "gut-kidney axis"), regulation of the immune system via the ALG3/PPAR-γ/NF-κB pathway, and inhibition of signaling pathways associated with fibrosis and apoptosis, such as the TGFβ/Smad, PI3K/AKT/mTOR, and GRP78/CHOP pathways. [1, 4, 9]

Brand names
Yishen Huashi Granule
Other names
Yishen Huashi Granule益肾化湿颗粒
02

Targets

NF-κBKL (Klotho Protein)PPARG (Peroxisome proliferator-activated receptor gamma)BMP2 (Bone morphogenetic protein 2)HSPA5 (Heat shock protein family A member 5)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Yi-Shen-Hua-Shi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi-Shen-Hua-Shi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call